» Authors » Antonio Lopez-Serrano

Antonio Lopez-Serrano

Explore the profile of Antonio Lopez-Serrano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 192
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Serrano A, Pretel L
Rev Esp Enferm Dig . 2025 Feb; 117(3):136-147. PMID: 39968657
Objective: to analyze the best evidence available on the usefulness of VCE versus DCE for dysplasia identification in patients with long-standing colonic IBD. Material And Methods: a qualitative, PRISMA 2020-based...
2.
Lorente J, Paredes J, Llopis P, Ripolles T, Voces A, Algarra A, et al.
Rev Esp Enferm Dig . 2024 Aug; 116(11):606-612. PMID: 39087667
Background: anti-TNF drugs have revolutionized the treatment of Crohn's disease (CD) and have set new therapeutic targets. A direct correlation between anti-TNF trough levels and endoscopic healing in inflammatory bowel...
3.
Lopez-Serrano A, Voces A, Lorente J, Santonja F, Algarra A, Latorre P, et al.
Gastroenterol Hepatol . 2024 May; 48(2):502210. PMID: 38740327
Background And Study Aim: High-definition virtual chromoendoscopy, along with targeted biopsies, is recommended for dysplasia surveillance in ulcerative colitis patients at risk for colorectal cancer. Computer-aided detection (CADe) systems aim...
4.
Medina-Prado L, Sala-Miquel N, Aicart-Ramos M, Lopez-Cardona J, Ponce-Romero M, Ortiz O, et al.
Cancer Med . 2024 Mar; 13(5):e6923. PMID: 38491824
Background And Study Aims: Our aim was to determine the impact of the SARS-CoV-2 pandemic on the diagnosis and prognosis of colorectal cancer (CRC). Patients And Methods: This prospective cohort...
5.
Latorre Ano P, Torrente Sanchez J, Perez Ibanez A, Tenias Burillo J, Moreno Sanchez N, Lopez-Serrano A, et al.
Rev Esp Enferm Dig . 2023 Apr; 115(10):553-558. PMID: 37114398
Aim: endoscopy identifies inflammatory activity, however, it is an unpleasant test and is not always accessible. The aim of the study was to compare the usefulness of quantitative fecal immunochemical...
6.
Lopez-Serrano A, Paredes J
Inflamm Bowel Dis . 2022 Apr; 28(7):e106. PMID: 35446955
No abstract available.
7.
Ballester M, Mesonero F, Florez-Diez P, Gomez C, Fuentes-Valenzuela E, Martin N, et al.
Aliment Pharmacol Ther . 2022 Feb; 55(11):1402-1413. PMID: 35224758
Background And Aims: Patients with colonic inflammatory bowel disease (IBD) have a high risk of colorectal cancer (CRC). Current guidelines recommend endoscopic surveillance, yet epidemiological studies show poor compliance. The...
8.
Jover R, Clofent J, de Vera F, Lopez-Serrano A, Gutierrez A, Aguas M, et al.
Gastroenterol Hepatol . 2021 May; 45(4):299-303. PMID: 34051311
The COVID-19 pandemic has meant a qualitative change in the way patients are treated in outpatient clinics. The need to take measures of social isolation as prevention for contagion by...
9.
Lopez-Serrano A, Suarez M, Beso P, Algarra A, Latorre P, Barrachina M, et al.
Scand J Gastroenterol . 2021 May; 56(7):820-828. PMID: 34043920
Objective: Patients with long-standing colonic inflammatory bowel disease (cIBD) are at increased risk of developing colorectal cancer (CRC). Dye-spray chromoendoscopy (DCE) with targeted biopsies is the preferred technique for surveillance...
10.
Rodriguez de Santiago E, Burgos-Santamaria D, Perez-Carazo L, Brullet E, Ciriano L, Riu Pons F, et al.
Gastrointest Endosc . 2019 Jun; 90(4):581-590.e6. PMID: 31220444
Background And Aims: TC-325 (Hemospray, Cook Medical, Winston-Salem, NC) is an inorganic hemostatic powder recently approved by the U.S. Food and Drug Administration. This study aimed to examine the effectiveness,...